JCI-accredited hospitals · 45+ hospitals & clinics · Patients from 90+ countries · 24/7 multilingual coordination
Neurology

Drug-Resistant Epilepsy: When Neuromodulation Becomes a Treatment Option

Published October 27, 2026
Why Consider Neuromodulation? — drug-resistant epilepsy

Drug-resistant epilepsy means seizures continue despite trials of two appropriate anti-seizure medicines. For selected people, neuromodulation devices can help reduce seizure frequency and severity when medicines alone do not provide adequate control.

Overview: What Is Drug-Resistant Epilepsy?

Epilepsy is a neurological condition in which a person has a tendency to experience recurrent unprovoked seizures. Many people achieve good seizure control with anti-seizure medicines. However, some continue to have seizures despite appropriate treatment. This is often called drug-resistant epilepsy, refractory epilepsy, or treatment-resistant epilepsy.

The widely used definition of drug-resistant epilepsy is failure to achieve sustained seizure freedom after trials of two appropriately chosen and tolerated anti-seizure medicines, used alone or together. This definition does not mean that further treatment cannot help. It signals that a specialist assessment is particularly important, because other approaches may offer meaningful benefits.

Drug-resistant epilepsy can affect safety, independence, education, work, sleep, mood, and quality of life. Seizure patterns differ widely: some people have occasional seizures, while others have frequent events. The goal of care is individualized and may include fewer seizures, less severe seizures, faster recovery, improved alertness, and better day-to-day functioning.

Why Consider Neuromodulation?

Why Consider Neuromodulation? — drug-resistant epilepsy

Neuromodulation is a treatment approach that uses carefully programmed electrical stimulation to influence the nervous system. In epilepsy, a small implanted device sends electrical pulses to a nerve or to selected brain areas involved in seizure activity. It is considered when seizures remain uncontrolled with medicines and when brain surgery to remove a seizure focus is not appropriate, is not desired, or is unlikely to be effective on its own.

Neuromodulation is not a single treatment. The most established device-based options for epilepsy include vagus nerve stimulation (VNS), responsive neurostimulation (RNS), and deep brain stimulation (DBS). The most suitable option depends on where seizures begin, whether there is one or more seizure-onset areas, the seizure type, brain imaging findings, age, general health, and personal treatment goals.

These devices generally reduce seizure burden over time rather than providing an immediate cure. Some people have substantial improvement, while others have a more modest response. Results are difficult to predict for an individual, so treatment decisions should be made with an experienced epilepsy team after a full discussion of likely benefits, limitations, and risks.

Types of Neuromodulation for Epilepsy

Types of Neuromodulation for Epilepsy — drug-resistant epilepsy

Vagus nerve stimulation (VNS) involves placing a pulse generator under the skin of the chest and connecting it to the left vagus nerve in the neck. The device delivers stimulation at regular intervals. Some systems also respond to physiologic changes associated with seizures, and some patients or caregivers can use a magnet to trigger extra stimulation around a seizure. VNS does not require electrodes to be placed in the brain.

Responsive neurostimulation (RNS) is designed for people whose seizures arise from one or two identified brain regions. Electrodes are placed near or within the seizure-onset area, and a device implanted in the skull monitors electrical activity. When it detects patterns associated with a seizure, it delivers brief stimulation intended to interrupt or modify that activity. The recorded data can also help the care team understand seizure patterns and adjust programming.

Deep brain stimulation (DBS) uses electrodes placed in a specific deep brain target that participates in seizure networks. A generator under the chest skin supplies regular stimulation. DBS may be considered in selected people with focal epilepsy, particularly when seizure activity involves wider networks or cannot be safely removed with resective surgery.

All implanted neurostimulation systems require follow-up visits for programming, monitoring, and eventual battery replacement or device maintenance. The device settings are adjusted gradually, balancing seizure control with comfort and side effects.

Assessment Before Treatment

Before neuromodulation is considered, the epilepsy diagnosis should be reviewed carefully. Some events that resemble seizures may have another cause, and seizure classification can change treatment choices. A detailed history, witness descriptions, medication review, neurological examination, and an assessment of physical and mental health all contribute to the evaluation.

Most candidates undergo testing at a comprehensive epilepsy center. This may include prolonged video-electroencephalography (video-EEG) monitoring, magnetic resonance imaging (MRI), neuropsychological assessment, and sometimes functional imaging or other specialized tests. These studies help identify where seizures begin, how they spread, and whether there is a potentially removable area of brain tissue.

For some people, doctors may recommend invasive EEG monitoring with electrodes placed on or in the brain. This is not needed for everyone, but it can provide more precise information when noninvasive testing does not clearly identify the seizure-onset zone. The results are reviewed by a multidisciplinary team that may include epileptologists, neurosurgeons, neuropsychologists, neuroradiologists, nurses, and rehabilitation professionals.

Evaluation also considers whether potentially reversible contributors are present, such as missed medication doses, sleep deprivation, alcohol or recreational drug use, medication interactions, or an incorrect diagnosis. If epilepsy surgery could safely remove the source of seizures, it may offer the best chance of seizure freedom for certain patients and should be discussed alongside neuromodulation.

Benefits, Risks, and What to Expect

The main expected benefit of neuromodulation is a reduction in seizure frequency, intensity, duration, or recovery time. Benefits may build gradually over months or years as stimulation is adjusted. Many people continue anti-seizure medicines after implantation, although medication plans may be reviewed over time. Stopping medicines without medical guidance can increase the risk of seizures.

Each procedure has specific considerations. VNS can cause temporary hoarseness, throat discomfort, cough, or a change in voice during stimulation. Brain-based devices such as RNS and DBS involve neurosurgery, so risks can include infection, bleeding, pain, wound healing problems, device malfunction, and anesthesia-related complications. The epilepsy team explains how these risks apply to the individual.

Follow-up is an essential part of treatment. Device programming is personalized and may require several adjustments before a useful balance is reached. People are usually asked to keep a seizure diary, note possible triggers and side effects, and attend scheduled reviews. For RNS, recorded device information may help guide treatment planning.

Neuromodulation does not remove the need for seizure safety measures. Depending on seizure type and local regulations, a person may need guidance about driving, swimming, heights, cooking, work hazards, and supervision. Families and caregivers can also benefit from learning seizure first aid.

Self-Care and Living With Epilepsy

Daily habits can support medical treatment, although they do not replace it. Taking anti-seizure medicines exactly as prescribed, maintaining regular sleep, eating consistently, staying hydrated, and managing stress may help reduce avoidable seizure triggers for some people. Alcohol, recreational drugs, and certain over-the-counter or prescription medicines can affect seizure control or interact with treatment, so they should be discussed with a clinician.

A seizure diary can be useful before and after neuromodulation. It may include the date and time of seizures, possible triggers, seizure features, recovery time, missed doses, menstrual cycle information when relevant, and device-related symptoms. Reliable records help the clinical team judge whether treatment changes are helping.

People with epilepsy should discuss pregnancy planning, contraception, bone health, mood symptoms, memory concerns, and sleep problems with their healthcare professional. These areas can be affected by epilepsy or its treatment and often have practical management options. Emotional support, counseling, support groups, and workplace or school accommodations may also be helpful.

At Acıbadem Health Point, multidisciplinary epilepsy and neuromodulation specialists in JCI-accredited hospitals assess and treat international patients using individualized diagnostic and treatment planning.

When to Seek Medical Help

Anyone who continues to have seizures despite taking anti-seizure medicines should ask for review by an epilepsy specialist. Referral to a comprehensive epilepsy center is especially important after two appropriate medicines have not achieved seizure freedom. A specialist can confirm the diagnosis and discuss medication optimization, dietary therapies, surgery, and neuromodulation where appropriate.

Emergency care is needed when a seizure lasts longer than five minutes, repeated seizures occur without full recovery between them, breathing is difficult, a serious injury occurs, or the person is pregnant, has diabetes, or is having a first seizure. A person’s individualized seizure action plan should be followed when one is available.

During a convulsive seizure, bystanders should stay calm, move harmful objects away, cushion the person’s head, loosen tight clothing around the neck, and time the seizure. They should not restrain the person or put anything in the mouth. Once movements stop, placing the person on their side can help keep the airway clear while they recover.

Frequently asked questions

01What does drug-resistant epilepsy mean?

Drug-resistant epilepsy usually means that a person has continued to have seizures after trying two anti-seizure medicines that were appropriate for their seizure type and were tolerated. It does not mean that treatment options have ended. A specialist evaluation can identify whether surgery, neuromodulation, dietary treatment, or another approach may help.

02Can neuromodulation cure epilepsy?

Neuromodulation is usually intended to reduce seizures rather than guarantee a cure. Some people experience major reductions in seizure frequency or severity, while others have a smaller improvement. The response can develop gradually as the device is programmed and treatment is monitored.

03Who may be eligible for epilepsy neuromodulation?

Eligibility depends on the seizure type, seizure-onset location, previous treatments, imaging and EEG findings, overall health, and personal preferences. It is often considered for people with drug-resistant epilepsy who are not suitable candidates for seizure-removal surgery or who still have seizures after surgery. A comprehensive epilepsy assessment is needed to determine the most appropriate option.

04Will a person still need epilepsy medicine after device implantation?

Many people continue anti-seizure medicines after receiving VNS, RNS, or DBS. Medication changes are individualized and are usually made gradually by the treating clinician. A person should never reduce or stop anti-seizure medication without medical advice.

05How long does it take for neuromodulation to work?

Improvement may not be immediate. Stimulation settings are generally adjusted over time, and seizure reduction may become clearer over months or longer. Regular follow-up and accurate seizure records help the team evaluate response and tailor programming.

06Are neuromodulation devices safe with MRI scans?

MRI compatibility varies by device model, implant location, and the type of scan being planned. Some systems can be scanned only under specific conditions, while others may have restrictions. Before any MRI or medical procedure, the person should tell the imaging team and their epilepsy specialist about the implanted device.

This article is for general information only and is not a substitute for professional medical advice. Please consult a qualified doctor about your individual situation.

Add Acıbadem on Google

Add us as a Preferred Source to see more of our trusted health content across Google Search, AI Overviews and Discover.

Share this page
Was this content helpful?
Your feedback helps us improve.
Keep Reading

More from the Health Library

We’re With You at Every Step

How can we help you today?

Treatments are delivered at our JCI-accredited hospitals — Acıbadem International
We value your privacy We use essential cookies to run this site and, with your consent, analytics cookies to understand how it is used and improve it. You can accept, reject, or choose what to allow. See our Cookie Policy.